Parkinson's disease is a neurodegenerative disease which affects more than 30 million patients worldwide. Massive progress has been made in the treatment of Parkinson’s disease. Several companies are offering novel therapies and treatments to treat the disease showing promising results in clinical trials. These include deep brain stimulation devices based treatments, stem cell based therapies, gene therapies and target drug delivery with potentially disease-modifying properties. Further growing capital investments such as Parkinson's Foundation’s investment of $4.2 million across 46 research grants to advance Parkinson’s disease research in 2019 will offer several growth opportunities in future.
This report analyses the global market for Parkinson’s Disease Treatment. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market. This Parkinson’s Disease Treatment market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Europe dominates the Global Parkinson’s disease Treatment market. The growth in the region is primarily due to presence of advanced healthcare infrastructure, sophisticated medical facilities, key players and growing prevalence of Parkinson’s disease. The region has more than 1 million people living with Parkinson’s today. Prevalence rate in the 60-69-year-old population is approximately 1.0% whereas in people over 80 its 2.7%. The figure is expected to double by 2030 with ageing population. Asia Pacific was fastest growing market with rising geriatric population in countries like China and Japan. The burden of disease is snowballing in China. It is projected that china will account about half of Parkinson’s disease population in the world by 2030. Significant rise in geriatric population in the country will drive growth in forecast period. It is estimated that country will have more than 26.9% population over 65 years old in 2050.
Growing geriatric population and prevalence of Parkinson’s disease around the world is driving the growth of Parkinson’s disease Treatment market. According to Parkinson’s foundation worldwide more than 10 million people are living with Parkinson’s disease. Significant surge in geriatric population will drive the growth in forecast period. According to United Nations globally there are 703 million people aged 65 years or more. By 2050 the number is expected to double to 1.5 billion. However, stringent regulatory policies, contradictions over present drug effectiveness and efficacy, adverse side effects are hampering the growth of global market. Ongoing clinical trials, new therapies based on deep brain stimulation will offer significant opportunities in the forecast period. For instance in August 2019 FDA approved Japan based Kyowa Kirin’s Nourianz (istradefylline) tablets to treat Parkinson’s disease in adults.
Market Segmentation •Drug Class oCarbidopa/Levodopa oCatechol-O-methyl transferase (COMT) inhibitors oDopamine agonists (non-ergoline) oDopamine precursors oMonoamine oxidase B inhibitors (MAO-B inhibitors) oOthers •Medical Devices oDeep Brain Stimulation (DBS) Devices oLevodopa Enteral Suspension delivery devices •Patient Care Setting oClinics oHospitals •Distribution Channel oOnline pharmacies oRetail pharmacies oHospital pharmacies Report Coverage •An overview of the global Parkinson’s Disease Treatment market •In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market •Global Parkinson’s Disease Treatment market revenue data historic and forecast analysis (2016 to 2026) •Characterization and quantification of the market segments for Parkinson’s Disease Treatment market •Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Parkinson’s Disease Treatment Market Report •What is the impact of COVID 19 epidemic on the global Parkinson’s Disease Treatment market? •Which is mostly affected region, country? •Which is the current largest and fastest-growing region? •What is the market size and growth rate of the global Parkinson’s Disease Treatment market? •What are current factors affecting the growth of market? •What are Key trends and opportunity areas? •Within Parkinson’s Disease Treatment market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment? •What are the major strategies adopted by leading market companies? •What are company challenges and essential success factors by market segment? •How company offerings and supply chain capabilities are shifting to meet emerging market needs?
About Industry Research Place
Industry research place offers you the best in class market research reports from top publishers. Our reports include credible source of expert insights and actionable solutions for enterprises to size their growth potentials. We partner with leading market analysis companies, research groups, consulting firms, institutes and individual publishers and consultants to provide you latest market findings.